Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism

被引:6
|
作者
Tamura, Naohisa [1 ,2 ]
Watanabe, Erika [3 ]
Shirakawa, Rumi [3 ]
Nakatani, Eiji [1 ]
Yamada, Kanako [2 ]
Hatakeyama, Hiroshi [2 ]
Torii-Hanakita, Mizuki [2 ]
Kyo, Chika [2 ]
Kosugi, Rieko [2 ,4 ]
Ogawa, Tatsuo [2 ]
Kotani, Masato [2 ]
Usui, Takeshi [1 ,4 ]
Inoue, Tatsuhide [2 ]
机构
[1] Shizuoka Prefectural Gen Hosp, Res Support Ctr, Shizuoka, Japan
[2] Shizuoka Prefectural Gen Hosp, Ctr Diabet Endocrinol & Metab, Shizuoka, Japan
[3] Shizuoka Prefectural Gen Hosp, Dept Clin Lab Med, Shizuoka, Japan
[4] Shizuoka Prefectural Gen Hosp, Dept Med Genet, Shizuoka, Japan
来源
PLOS ONE | 2021年 / 16卷 / 07期
关键词
HARMONIZATION; COMPLICATIONS; IMMUNOASSAYS; JAPAN;
D O I
10.1371/journal.pone.0253807
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Determining values of plasma renin activity (PRA) or plasma active renin concentration (ARC), plasma aldosterone concentration (PAC), and aldosterone-to-renin ratio (ARR) is essential to diagnose primary aldosteronism (PA), but it takes several days with conventional radioimmunoassays (RIAs). Chemiluminescent enzyme immunoassays for PAC and ARC using the Accuraseed(R) immunoanalyzer facilitated the determination, but relations between Accuraseed(R) immunoanalyzer-based and RIA-based values in samples of PA confirmatory tests and adrenal venous sampling remained to be elucidated. We addressed this issue in the present study. This is a prospective, cross-sectional study. ARC and PAC values were measured by the Accuraseed(R) immunoanalyzer in samples, in which PRA and PAC values had been measured by the PRA-FR(R) RIA and SPAC(R)-S Aldosterone kits, respectively. The relations between Accuraseed(R) immunoanalyzer-based and RIA-based values were investigated with regression analyses. The optimal cutoff of Accuraseed(R) immunoanalyzer-based ARR for PA screening was determined by the receiver operating characteristic analysis. After log-log transformations, linear relations with high coefficients of determination were observed between Accuraseed(R) immunoanalyzer-based and RIA-based data of renin and aldosterone. Following the PA guidelines of Japan Endocrine Society, Accuraseed(R) immunoanalyzer-based cutoffs were calculated from the regression equations: the basal PAC for PA screening >12 ng/dL, PAC for the saline infusion test >8.2 ng/dL, ARC for the furosemide-upright test <15 pg/mL, and ARR for the captopril challenge test >3.09 ng/dL per pg/mL. The optimal cutoff of Accuraseed(R) immunoanalyzer-based ARR for PA screening was >2.43 ng/dL over pg/mL not to overlook bilateral PA patients. The present study provided conversion formulas between Accuraseed(R) immunoanalyzer-based and RIA-based values of renin, aldosterone, and ARR, not only in basal samples but also in samples of PA confirmatory tests and adrenal venous sampling. Although validation studies are awaited, the present study will become priming water of harmonization of renin and aldosterone immunoassays.
引用
收藏
页数:23
相关论文
共 29 条
  • [1] RADIOIMMUNOASSAYS OF PLASMA ALDOSTERONE AND PLASMA-RENIN ACTIVITY - APPLICATION TO DIAGNOSIS OF PRIMARY ALDOSTERONISM
    CORVOL, P
    MENARD, J
    BERTAGNA, X
    ANNALES D ENDOCRINOLOGIE, 1973, 34 (01) : 57 - 65
  • [2] Screening for Primary Aldosteronism: Aldosterone to Renin Ratio (ARR) Using Two Automated Chemiluminescent Immunoassays
    Bidlingmaier, Martin
    Schmidt, Harald
    Milczynski, Christoph
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [3] COMPARISON BETWEEN ALDOSTERONE AND RENIN MEASUREMENT BY CHEMILUMINESCENT IMMUNOASSAY AND RADIOIMMUNOASSAY FOR THE DIAGNOSIS OF PRIMARY ALDOSTERONISM
    Burrello, J.
    Buffolo, F.
    Monticone, S.
    Viola, A.
    Falcetta, A.
    Lucchiari, M.
    Mengozzi, G.
    Rabbia, F.
    Veglio, F.
    Mulatero, P.
    JOURNAL OF HYPERTENSION, 2015, 33 : E121 - E121
  • [4] Novel chemiluminescent immunoassay to measure plasma aldosterone and plasma active renin concentrations for the diagnosis of primary aldosteronism
    Kyoko Teruyama
    Mitsuhide Naruse
    Mika Tsuiki
    Hiroki Kobayashi
    Journal of Human Hypertension, 2022, 36 : 77 - 85
  • [5] Novel chemiluminescent immunoassay to measure plasma aldosterone and plasma active renin concentrations for the diagnosis of primary aldosteronism
    Teruyama, Kyoko
    Naruse, Mitsuhide
    Tsuiki, Mika
    Kobayashi, Hiroki
    JOURNAL OF HUMAN HYPERTENSION, 2022, 36 (01) : 77 - 85
  • [6] Automated Mindray CL-1200i chemiluminescent assays of renin and aldosterone for the diagnosis of primary aldosteronism
    Cosma, Chiara
    Padoan, Andrea
    Plebani, Mario
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (05) : E215 - E217
  • [7] Screening for primary aldosteronism: Implications of an increased plasma aldosterone/renin ratio
    Schwartz, GL
    Chapman, AB
    Boerwinkle, E
    Kisabeth, RM
    Turner, ST
    CLINICAL CHEMISTRY, 2002, 48 (11) : 1919 - 1923
  • [8] Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism
    Bernini, Giampaolo
    Moretti, Angelica
    Orlandini, Cinzia
    Berti, Piero
    Miccoli, Paolo
    Bardini, Michele
    Taurino, Chiara
    Bernini, Matteo
    Salvetti, Antonio
    JOURNAL OF HYPERTENSION, 2008, 26 (05) : 981 - 988
  • [9] Aldosterone, Plasma Renin Activity and Aldosterone-Renin Ratio in Normotensive Pediatric Population as Screening for Primary Aldosteronism
    Aglony, M.
    Martinez, A.
    Campino, C.
    Garcia, H.
    Bancalari, R.
    Bolte, L.
    Avalos, C.
    Loureiro, C.
    Carvajal, C.
    Fardella, C.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1951 - 1951
  • [10] Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism
    Kobayashi, Hiroki
    Nakamura, Yoshihiro
    Abe, Masanori
    Tanabe, Akiyo
    Sone, Masakatsu
    Katabami, Takuyuki
    Kurihara, Isao
    Ichijo, Takamasa
    Tsuiki, Mika
    Izawa, Shoichiro
    Wada, Norio
    Yoneda, Takashi
    Takahashi, Katsutoshi
    Tamura, Kouichi
    Ogawa, Yoshihiro
    Inagaki, Nobuya
    Yamamoto, Koichi
    Rakugi, Hiromi
    Naruse, Mitsuhide
    ENDOCRINE JOURNAL, 2023, 70 (05) : 489 - 500